Hannes Hagström
banner
liverepi.bsky.social
Hannes Hagström
@liverepi.bsky.social
Professor in gastroenterology and hepatology @KarolinskaInst. Adjunct editor @JInternMed. Interest in liver disease, especially MASLD/MASH, public health, epidemiology.
Reposted by Hannes Hagström
New review from researchers at #Karolinskainstitutet! Health inequalities in the Nordic countries: A comparative overview and update

🔗https://doi.org/10.1111/joim.70029

#healthinequality #mortality
October 17, 2025 at 7:55 AM
Reposted by Hannes Hagström
New Original Article! Systemic neutrophil activation and N-formyl methionine-formyl peptide receptor-1 signaling define inflammatory endotypes in rheumatoid arthritis-associated lung involvement

🔗https://doi.org/10.1111/joim.70030

#FPR1 #rheumatoidarthritis #interstitiallungdisease #mitochondria
October 17, 2025 at 8:09 AM
Reposted by Hannes Hagström
New Original Article to read! Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk

🔗https://doi.org/10.1111/joim.70026

#IBD #PSC #colorectalcancer #livertransplant
October 17, 2025 at 8:20 AM
Reposted by Hannes Hagström
Nathan Gill is no fringe politician.

He was the leader of the Reform Party and before that UKIP in Wales.

A Brexit Party MEP.

A friend and ally of Nigel Farage, who in 2016 called him:

"terrific," and "as honest as the day is long."

This is a MASSIVE story

www.bbc.co.uk/news/article...
Reform UK's ex-Wales leader Nathan Gill admits pro-Russia bribery
Nathan Gill admits eight charges of bribery while being a Member of the European Parliament.
www.bbc.co.uk
September 27, 2025 at 10:05 AM
Reposted by Hannes Hagström
A man in Arizona just died from pneumonic plague.

Before you freak out, here are 5 things you need to know about plague.

LInk: open.substack.com/pub/epiellie...
Plague Death in Arizona: 5 Things you Need to Know
Yesterday, Coconino County, Arizona reported the death of a man from pneumonic plague.
open.substack.com
July 12, 2025 at 3:12 PM
Reposted by Hannes Hagström
Welcome to read the Editor´s Choice in July!

➡️Accumulating understanding that diet, stress, toxins, and infections affect offspring health.

🔗 doi.org/10.1111/joim.20094
👉Also, read the July issue: onlinelibrary.wiley.com/toc/13652796/2025/298/1

#epigenetics #inflammatorymemory
July 4, 2025 at 8:00 AM
Reposted by Hannes Hagström
New Review Article to read! Gaucher disease, state of the art and perspectives #gaucherdisease #glucocerebrosidase #lysosomes

🔗Read here: doi.org/10.1111/joim...
July 4, 2025 at 12:34 PM
Reposted by Hannes Hagström
New Editorial! Community prevalence of advanced liver fibrosis in Type 2 diabetes—How big is the challenge? #MASLD #T2D

🔗 doi.org/10.1111/joim...
👉This Editorial comments on: doi.org/10.1111/joim...
<em>Journal of Internal Medicine</em> | Wiley Online Library
Click on the article title to read more.
doi.org
July 2, 2025 at 12:32 PM
Reposted by Hannes Hagström
Read the News Release! Fatty liver – but not liver damage – common in type 2 diabetes | EurekAlert! www.eurekalert.org/news-release...
Fatty liver – but not liver damage – common in type 2 diabetes
Six out of ten people with type 2 diabetes had fatty liver in a new study from Link&ouml;ping University in Sweden. Of these, only a small percentage had developed more severe liver disease. The study...
www.eurekalert.org
June 18, 2025 at 3:25 AM
New review from us: Clinical Utility of Non-Invasive Tests for Liver Fibrosis in People Living With Alpha-1 Antitrypsin Deficiency. Happy to coauthor with leading experts and led by Joost Boeckmans. Nice start of a new project on AATD using Swedish data.

onlinelibrary.wiley.com/doi/10.1111/...
Clinical Utility of Non‐Invasive Tests for Liver Fibrosis in People Living With Alpha‐1 Antitrypsin Deficiency
Severe alpha-1 antitrypsin deficiency (AATD) is a rare genetic condition characterised by low systemic levels of alpha-1 antitrypsin due to its retention in the liver. Consequently, it predisposes in...
onlinelibrary.wiley.com
June 6, 2025 at 4:31 PM
Reposted by Hannes Hagström
Our medical staff are donating their own blood to provide life-saving treatment for patients in #Gaza.

Patients that were gunned down while trying to get food.

Food for their families.

Food to live.

We need an immediate #ceasefire, now.
June 5, 2025 at 7:10 PM
Reposted by Hannes Hagström
Continuing today! The 19th Key symposium 2025: Planetary Health – connect the dots. What saves the planet saves our health!

19-21 May in Stockholm, Sweden.

Gunhild Stordalen opens today´s program: key-symposium2025.se

#PlanetaryHealth25
May 20, 2025 at 6:46 AM
Reposted by Hannes Hagström
April 28, 2025 at 1:09 PM
Reposted by Hannes Hagström
The #JSGE @myueg.bsky.social symposium with #lenakristinconradi and @liverepi.bsky.social on using a metabolic switch in #pancreaticcancer for therapy and #MASLD respectively. Truly worth their #risingstar awards!
April 24, 2025 at 10:22 AM
🚨New paper from us in Journal of Hepatology - Using PEth values on >50,000 persons to predict outcomes. www.sciencedirect.com/science/arti...
Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes
Phosphatidylethanol (PEth) is an ethanol metabolite used as a specific biomarker for recent alcohol consumption. We aimed to determine the proportion …
www.sciencedirect.com
April 13, 2025 at 8:58 AM
Reposted by Hannes Hagström
FDA approves first therapy for IgG4-related disease

www.medscape.com/viewarticle/...

#GastroSky #MedSky #RheumSky
FDA Approves First and Only Therapy for IgG4-RD
The CD19+ B-Cell targeted therapy reduced flare risk by 87% in a phase 3 clinical trial.
www.medscape.com
April 9, 2025 at 8:40 AM
Reposted by Hannes Hagström
Are you a researcher active outside of Europe who might consider coming to Sweden? Check out this @vetenskapsradet.bsky.social grant for recruitment of international visiting researchers!
www.vr.se/english/appl...
Grant for recruiting international visiting researchers to Sweden
The purpose of the grant is to provide higher education institutions and other research organisations the opportunity to develop and strengthen a research field by recruiting a distinguished researche...
www.vr.se
April 8, 2025 at 3:20 PM
Vote for Peter Stenvinkel as a "Sommar" radio show host: www.sverigesradio.se/artikel/kand...

Would be such a nice experience!
7. Den smarta naturen – Peter Stenvinkel - Sommar & Vinter i P1
Utmaningarna vår värld står inför tycks oändliga. Men tänk om det inte är så? I detta Sommarprat får vi lära oss hur vi med hjälp av forskning, naturens ...
www.sverigesradio.se
April 8, 2025 at 8:28 AM
New from Juan Vaz in our group: www.sciencedirect.com/science/arti...

In >5400 patients with primary liver cancer (HCC), those with lower socio-economic parameters such as income levels have more advanced tumors at diagnosis, less frequently receive curative treatments and have poorer prognosis.
Socioeconomic inequalities in diagnostics, care and survival outcomes for hepatocellular carcinoma in Sweden: a nationwide cohort study
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. This study evaluates how strongly socioeconomic factors assoc…
www.sciencedirect.com
March 26, 2025 at 6:49 AM
New paper from us in @jhepatology.bsky.social: www.journal-of-hepatology.eu/article/S016...
Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden
Data on cause-specific mortality in metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. We aimed to determine the rate and risk of death from different causes in patients wit...
www.journal-of-hepatology.eu
March 24, 2025 at 7:51 PM
Interesting study from Alina Allen's group: pubmed.ncbi.nlm.nih.gov/40105977/

Reassuring that MASLD diagnosis identified through screening led to weight loss and no major issues with increased anxiety.
Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease - PubMed
Screening for diseases can have psychological impacts, such as anxiety, and requires acceptability from the population to be effective. This study examined the perspectives on the benefits and harms o...
pubmed.ncbi.nlm.nih.gov
March 21, 2025 at 7:35 AM
Reposted by Hannes Hagström
Have you secured your spot for #EASLCongress 2025 on 7-10 May?

🌍Join us in Amsterdam or online to transform liver care worldwide! easlcongress.eu/2025-registr...
📜The deadline to submit your late-breaker abstract is TODAY, 17 March! easlcongress.eu/2025-abstrac...
March 17, 2025 at 8:51 AM